| scholarly article | Q13442814 |
| P2093 | author name string | Robert E Click | |
| P2860 | cites work | Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario | Q21092926 |
| Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain? | Q21198788 | ||
| Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus | Q21562352 | ||
| Primary treatment of Crohn’s disease: combined antibiotics taking center stage | Q22241483 | ||
| Mycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammation | Q22241484 | ||
| Adverse effects of biologics: a network meta-analysis and Cochrane overview | Q24234197 | ||
| The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO | Q24336822 | ||
| Bacterial evolution | Q24634394 | ||
| Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities | Q24681823 | ||
| Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine | Q24685403 | ||
| Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure? | Q28211872 | ||
| Sensing of bacteria: NOD a lonely job | Q28278372 | ||
| Durable alteration of the colonic microbiota by the administration of donor fecal flora | Q28290783 | ||
| Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease | Q28306336 | ||
| Association of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patients | Q28741088 | ||
| Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. | Q30635230 | ||
| Review article: the evidence base for interventions used to maintain remission in Crohn's disease | Q33301742 | ||
| Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis. | Q33866294 | ||
| Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis | Q33894352 | ||
| Hematopoietic cell transplantation for Crohn's disease; is it time? | Q34017756 | ||
| Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. | Q34156214 | ||
| Probiotic therapy of intestinal inflammation and infections. | Q34554746 | ||
| Probiotics: progress toward novel therapies for intestinal diseases | Q34565839 | ||
| Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. | Q34652744 | ||
| Comparison of ante-mortem assays to assess progression/regression of paratuberculosis in individual dairy animals | Q34775398 | ||
| A 60-day probiotic protocol with Dietzia subsp. C79793-74 prevents development of Johne's disease parameters after in utero and/or neonatal MAP infection | Q35214611 | ||
| Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. | Q35594940 | ||
| Combined Streptomycin-Isoniazid-Rifampin Therapy in the Treatment of Johne's Disease in a Goat | Q35622223 | ||
| Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chr | Q35693684 | ||
| Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. | Q35760489 | ||
| Review article: practical management of inflammatory bowel disease patients taking immunomodulators | Q36166363 | ||
| Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. | Q36383345 | ||
| Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis. | Q36452334 | ||
| Use of antibiotics in the treatment of inflammatory bowel disease | Q36521201 | ||
| Identification of Mycobacterium avium complex in sarcoidosis. | Q36538010 | ||
| A new look at Crohn's disease: breakdown of the mucosal antibacterial defense | Q36631495 | ||
| Crohn's disease and the mycobacterioses: a review and comparison of two disease entities | Q36634773 | ||
| Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars | Q36763393 | ||
| Treatment of Mycobacterium Paratuberculosis Infection in Ruminants | Q36868631 | ||
| Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis | Q36917257 | ||
| In utero infection of cattle with Mycobacterium avium subsp. paratuberculosis: a critical review and meta-analysis | Q36967547 | ||
| The evidence for Mycobacterium paratuberculosis in Crohn's disease | Q37016731 | ||
| The genus Dietzia: a new home for some known and emerging opportunist pathogens | Q37374330 | ||
| Innate antimicrobial immunity in inflammatory bowel diseases | Q37786633 | ||
| Optimal use of biologics in the management of Crohn's disease | Q37823322 | ||
| Detection of Mycobacterium avium ss. Paratuberculosis in Blau Syndrome Tissues | Q38413181 | ||
| Ruminant paratuberculosis (Johne's disease): the current status and future prospects | Q40179729 | ||
| Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: destination Sardinia, or beyond? | Q40481202 | ||
| Preclinical and clinical manifestations of paratuberculosis (including pathology). | Q41128846 | ||
| Treatment of clinical paratuberculosis in cattle. | Q41128868 | ||
| The pathology and pathogenesis of paratuberculosis in ruminants and other species | Q41468036 | ||
| Assessment of Dietzia subsp. C79793-74 for treatment of cattle with evidence of paratuberculosis | Q42713291 | ||
| Crohn's disease as an immunodeficiency | Q43203641 | ||
| Association between CARD15/NOD2 gene polymorphisms and paratuberculosis infection in cattle | Q43970978 | ||
| Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan | Q45136861 | ||
| Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. | Q45966647 | ||
| Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. | Q54700741 | ||
| NOD2/CARD15 mutations in Croatian patients with Crohn??s disease: prevalence and genotype???phenotype relationship | Q57265435 | ||
| Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease | Q60711896 | ||
| L'acide N-glycolyl-muramique, constituant des parois de Mycobacterium smegmatis: Identification par spectrometrie de masse | Q77921782 | ||
| Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis | Q79866560 | ||
| Antimycobacterial therapy in Crohn's disease: game over? | Q80480867 | ||
| Anti-mycobacterials and Crohn's disease | Q81663775 | ||
| Short communication: progression of Johne's disease curtailed by a probiotic | Q84570197 | ||
| Identification of seroreactive proteins in the culture filtrate antigen of Mycobacterium avium ssp. paratuberculosis human isolates to sera from Crohn's disease patients | Q84822599 | ||
| P304 | page(s) | 117 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Mycobacterial diseases : tuberculosis & leprosy | Q27725292 |
| P1476 | title | A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease | |
| P478 | volume | 2 |
| Q91651439 | Characteristics and Epidemiological Investigation of Paratuberculosis in Dairy Cattle in Tai'an, China |
| Q64389203 | Single-Homology-Arm Linear DNA Recombination by the Nonhomologous End Joining Pathway as a Novel and Simple Gene Inactivation Method: a Proof-of-Concept Study in sp. Strain DQ12-45-1b |
Search more.